The story of Viagra, and its parent company copyright, presents a challenging case study for investors. Initially a blockbuster drug, generating billions in income, its intellectual property lapse created a wave of knock-off medications, significantly diminishing its market share . While some businesses may try to capitalize on male sexual dysfunct